Vascudyne

company

About

Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.

  • 1 - 10

Details

Last Funding Type
Grant
Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.

Vascudyne is the world's leading center of excellence for developing and manufacturing engineered tissue. We provide our clients with world-class engineered tissue, unique engineered tissue-based device designs, manufacturing capabilities, technical expertise, and product development support.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Vascudyne has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 10, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 10, 2022 Grant 1 Regenerative Medicine Minnesota Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Vascudyne is funded by 1 investors. Regenerative Medicine Minnesota are the most recent investors.
Investor Name Lead Investor Funding Round
Regenerative Medicine Minnesota Yes Grant